Quest Diagnostics Operating Expenses 2010-2024 | DGX

Quest Diagnostics annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Quest Diagnostics operating expenses for the quarter ending September 30, 2024 were $2.158B, a 10.5% increase year-over-year.
  • Quest Diagnostics operating expenses for the twelve months ending September 30, 2024 were $8.287B, a 1.47% increase year-over-year.
  • Quest Diagnostics annual operating expenses for 2023 were $7.99B, a 5.5% decline from 2022.
  • Quest Diagnostics annual operating expenses for 2022 were $8.455B, a 0.57% increase from 2021.
  • Quest Diagnostics annual operating expenses for 2021 were $8.407B, a 12.6% increase from 2020.
Quest Diagnostics Annual Operating Expenses
(Millions of US $)
2023 $7,990
2022 $8,455
2021 $8,407
2020 $7,466
2019 $6,495
2018 $6,430
2017 $6,237
2016 $5,937
2015 $6,094
2014 $6,452
2013 $5,671
2012 $6,182
2011 $6,405
2010 $5,977
2009 $6,096
Quest Diagnostics Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $2,158
2024-06-30 $2,042
2024-03-31 $2,066
2023-12-31 $2,021
2023-09-30 $1,953
2023-06-30 $1,990
2023-03-31 $2,026
2022-12-31 $2,198
2022-09-30 $2,094
2022-06-30 $2,065
2022-03-31 $2,098
2021-12-31 $2,208
2021-09-30 $2,122
2021-06-30 $2,017
2021-03-31 $2,060
2020-12-31 $2,207
2020-09-30 $2,068
2020-06-30 $1,544
2020-03-31 $1,647
2019-12-31 $1,563
2019-09-30 $1,643
2019-06-30 $1,646
2019-03-31 $1,643
2018-12-31 $1,619
2018-09-30 $1,585
2018-06-30 $1,614
2018-03-31 $1,612
2017-12-31 $1,596
2017-09-30 $1,558
2017-06-30 $1,545
2017-03-31 $1,538
2016-12-31 $1,284
2016-09-30 $1,563
2016-06-30 $1,484
2016-03-31 $1,606
2015-12-31 $1,610
2015-09-30 $1,249
2015-06-30 $1,624
2015-03-31 $1,611
2014-12-31 $1,626
2014-09-30 $1,648
2014-06-30 $1,640
2014-03-31 $1,538
2013-12-31 $1,486
2013-09-30 $1,099
2013-06-30 $1,526
2013-03-31 $1,560
2012-12-31 $1,509
2012-09-30 $1,517
2012-06-30 $1,545
2012-03-31 $1,611
2011-12-31 $1,444
2011-09-30 $1,584
2011-06-30 $1,586
2011-03-31 $1,791
2010-12-31 $1,433
2010-09-30 $1,528
2010-06-30 $1,509
2010-03-31 $1,507
2009-12-31 $1,518
2009-09-30 $1,549
2009-06-30 $1,542
2009-03-31 $1,487
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $18.259B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 0.00
DaVita (DVA) United States $13.572B 17.55
Encompass Health (EHC) United States $10.188B 24.02
Chemed (CHE) United States $8.593B 26.41
Elanco Animal Health (ELAN) United States $6.605B 15.72
RadNet (RDNT) United States $6.073B 134.49
Option Care Health (OPCH) United States $3.936B 18.65
Amedisys (AMED) United States $2.969B 21.13
LifeStance Health (LFST) United States $2.832B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.254B 26.45
U.S Physical Therapy (USPH) United States $1.477B 38.82
Aveanna Healthcare Holdings (AVAH) United States $1.128B 0.00
Pennant (PNTG) United States $1.070B 43.25
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00